Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Much Is the Global Antiparasitic Drugs Market Valued at Present and by 2029?

Recent years have seen robust growth in the size of the antiparasitic drugs market. It is projected to expand from a value of $24.06 billion in 2024 to $25.58 billion in 2025, signifying a compound annual growth rate (CAGR) of 6.3%. This good performance for the market in the historic period can be credited to the high incidence of parasitic infections, the resistance observed towards currently available treatments, and worldwide health initiatives.

The market for antiparasitic drugs is anticipated to witness solid expansion over the next few years, reaching a value of “$33.29 billion in 2029 with a compound annual growth rate (CAGR) of 6.8%“. The pronounced growth within the predicted timeframe can be linked to the rise in parasitic threats, changes in the climate, the emergence of vector-borne diseases, the heightened focus on worldwide health security, and improved healthcare access. The forecast period is also expected to see prominent trends such as advancements in the production of drugs, targeted treatment strategies, multipart therapies, collaborations between public and private entities, as well as the growth of telemedicine and remote diagnostic procedures.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12927&type=smp

#What Drivers Are Influencing Growth In The Antiparasitic Drugs Market?

The surge in cases of diseases spread by vectors is anticipated to fuel the antiparasitic drugs market’s expansion. Diseases transmitted by vectors, such as mosquitoes, ticks, and flies, refer to infectious illnesses passed on to humans or other animals via the biting arthropods, the primary vectors. Illnesses like malaria, dengue, and yellow fever qualify as examples of vector-borne diseases. Antiparasitic medications play a vital part in curbing the spread of such diseases by targeting and eradicating the causing parasites. Several antiparasitic medications like chloroquine, doxycycline, and atovaquone-proguanil are frequently utilized for treating malaria. For instance, data from the Centers for Disease Control and Prevention, a Government agency from the United States, shows that from January to June 2024, dengue cases reported across the Americas exceeded 9.7 million, about two-fold increase from the 4.6 million cases recorded in 2023. Within the United States, Puerto Rico registered 1,498 dengue cases and 745 cases were detected among U.S. travelers returning from infected regions. Hence, the rising prevalence of vector-borne diseases instigates the growth of the antiparasitic drugs market.

The antiparasitic drugs market covered in this report is segmented –

1) By Product Type: Anthelmintics, Antiprotozoals, Ectoparasiticide, Other Products

2) By Treatment: Avermectins, Bezimidazoles, Pyrimidines, Organophosphates, Imidazolesthiazoles

3) By Route of Administration: Oral, Injectable, Topical

4) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users

Subsegments:

1) By Anthelmintics: Benzimidazoles, Ivermectin, Pyrantel Pamoate, Praziquantel

2) By Antiprotozoals: Metronidazole, Tinidazole, Nitazoxanide, Pentamidine

3) By Ectoparasiticides: Permethrin, Malathion, Lindane, Fipronil

4) By Other Products: Combination Antiparasitic Drugs, Novel Antiparasitic Agents

Which Trends Are Redefining The Future Landscape Of The Antiparasitic Drugs Industry?

Top firms in the antiparasitic drugs market are prioritizing the creation of innovative offerings, like chewable veterinary goods, to enhance the ease of giving medication and boost pet compliance. These chewable veterinary products are flavored, easy-to-use tablets or treatments that deliver medicine to animals, making the treatment experience more palatable and less stressful for pets. For example, in April 2024, the German pharmaceutical company C.H. Boehringer Sohn AG and Co. KG launched NexGard Spectra to offer comprehensive parasite defense. NexGard SPECTRA is a tasty, soft chew capable of providing broad spectrum parasite protection for dogs—it handles fleas, ticks, heartworms, and several intestinal worms with just one monthly dose. It’s highly effective, killing fleas within a four-hour window after being given, and attaining over 99% efficacy against a range of parasites shortly thereafter.

Which Companies Play A Key Role In The Development Of The Antiparasitic Drugs Market?

Major companies operating in the antiparasitic drugs market are Pfizer Inc., Johnson & Johnson, Cadila Pharmaceuticals, Merck & Co.Inc., Bayer AG, Novartis AG, Sanofi S.A., GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim group, Zoetis Inc., Eisai Co. Ltd., Covetrus Inc., IDEXX Laboratories Inc., Dr. Reddy’s Laboratories, Intas Pharmaceuticals Ltd., Alkem Laboratories Ltd., Ceva Sante Animale S.A., Elanco Animal Health Incorporated, Phibro Animal Health Corporation, Norbrook Laboratories Ltd., Mankind Pharma, Neogen Corporation, Bimeda Inc., Indoco Remedies Ltd., ECO Animal Health, Lincoln Pharmaceuticals Ltd., Laboratorios Calier.

https://www.thebusinessresearchcompany.com/report/antiparasitic-drugs-global-market-report

What Are The Key Regional Developments Shaping The Antiparasitic Drugs Market?

North America was the largest region in the antiparasitic drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in antiparasitic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12927&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model